Research Progress on Bioactive Metal Complexes against ER-Positive Advanced Breast Cancer
Journal of Medicinal Chemistry · 23.02.2023 · 66 (4) · 2235-2256
DOI: 10.1021/acs.jmedchem.2c01458 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Medicinal Chemistry, online erschienen am 13.02.2023. Verfasst von Zhenlin Liang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Jiangsu Collaborative Innovation Center of Chinese Medicinal Resources Industrialization, School of Medicine & Holistic Integrative Medicine, Nanjing…. Hauptthemen laut MEDLINE: Breast Neoplasms, Coordination Complexes. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 115 Literaturangaben. Gefördert von: Nanjing University of Chinese Medicine, Jiangsu Provincial Department of Education, National Natural Science Foundation of China.
Abstract (Originalsprache)
Breast cancer is the most prevalent cancer in women and represents a serious disease that is harmful to life and health. In 1977, with the approval of tamoxifen, endocrine therapy has become the main clinical treatment for ER-positive (ER+) breast cancer. Although patients initially respond well to endocrine therapies, drug resistance often emerges and side effects can be challenging. To overcome drug resistance, the exploration for new drugs is a priority. Metal complexes have demonstrated significant antitumor activities, and platinum complexes are widely used in the clinic against various cancers, including breast cancer. In this Perspective, the first section describes the classification and mechanism of endocrine therapy drugs for ER+ breast cancer, and the second section summarizes research since 2000 into metal complexes with activity toward ER+ breast cancer. Finally, we discuss the opportunities, challenges, and future directions for metal complexes in the treatment of ER+ breast cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Jiangsu Collaborative Innovation Center of Chinese Medicinal Resources Industrialization, School of Medicine & Holistic Integrative Medicine, Nanjing University of Chinese Medicine, Nanjing, 210023, P. R. China.
- State key Laboratory of Coordination Chemistry, Nanjing University, Nanjing, 210023, P. R. China.
ORCID-Profile: Wukun Liu
Förderung
- Nanjing University of Chinese Medicine
- Jiangsu Provincial Department of Education
- National Natural Science Foundation of China
- Jiangsu Commission of Health
- Priority Academic Program Development of Jiangsu Higher Education Institutions
- State Key Laboratory of Coordination Chemistry (Nanjing University)
Zitieren
APA
Liang, Z., Liu, L., Zhou, Y., Liu, W., & Lu, Y. (2023). Research Progress on Bioactive Metal Complexes against ER-Positive Advanced Breast Cancer. Journal of Medicinal Chemistry, 66(4), 2235-2256. https://doi.org/10.1021/acs.jmedchem.2c01458
Vancouver
Liang Z, Liu L, Zhou Y, Liu W, Lu Y. Research Progress on Bioactive Metal Complexes against ER-Positive Advanced Breast Cancer. Journal of Medicinal Chemistry. 2023;66(4):2235-2256. doi:10.1021/acs.jmedchem.2c01458
BibTeX
@article{Liang2023,
author = {Liang, Zhenlin and Liu, Lijuan and Zhou, Yanyu and Liu, Wukun and Lu, Yunlong},
title = {Research Progress on Bioactive Metal Complexes against ER-Positive Advanced Breast Cancer},
journal = {Journal of Medicinal Chemistry},
year = {2023},
volume = {66},
number = {4},
pages = {2235--2256},
doi = {10.1021/acs.jmedchem.2c01458}
}
EUVIMED